DEXCOM INC — Director's Dealing 2020

Dec 30, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2020-12-28

Reporting Person: Murphy Patrick Michael (EVP, Chief Legal Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-28	Common Stock	S	500	$355.39	Disposed	19078	Direct

Footnotes

F1: On August 28, 2020, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2: Included in this number are 17,471 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 5,857 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 2,803 of which were granted on March 8, 2018 and shall vest through March 8, 2021.